Presentation Details:
Dr. Jehan Budak reviews important research abstracts from the CROI 2025 conference, focusing on studies of long-acting ART, like cabotegravir-rilpivirine, and novel ARV agents, such as the combination of doravirine with islatravir.
Presentation Transcript: